Kyverna Therapeutics, Inc.
USD7.90
-0.32 (-3.89%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.11
Prev. Close
$8.22
Day Low
$7.57
Day High
$8.20
52W Low
$2.52
52W High
$13.67
Market Cap
$0.35B
Volume
1.61M
| 20,582 |
| $8.59 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | Shaw Christi | director, officer: Executive Chairperson | F-InKind | Disposed | 4,194 | $8.59 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 20,582 | $8.59 |
| 20 May 2026 | Martini Gregory S. | Chief Financial Officer | A-Award | Acquired | 325,000 | $8.54 |